乳腺癌匹配病例控制分析 - 影响感染SARS-CoV-2风险的特定因素
Michael Pierro1, Joanna Zurko2, Anika Szabo3
1Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, mpierro@mcw.edu.
概括
接受乳腺癌活性化疗的妇女患COVID-19的风险明显更高. 这一发现强调了对这些患者持续采取预防措施的必要性.
科学领域:
- 在瘤学瘤学.
- 传染性疾病 传染性疾病
- 流行病学 流行病学
背景情况:
- COVID-19 流行病给癌症患者带来了独特的挑战.
- 了解乳腺癌患者COVID-19的风险因素对于管理至关重要.
研究的目的:
- 为了确定COVID-19发展的乳腺癌相关风险因素.
- 描述被诊断为COVID-19的乳腺癌患者的结果.
主要方法:
- 进行了一项追溯匹配病例控制研究.
- 病例是患有COVID-19的乳腺癌患者;对照组是没有COVID-19的乳腺癌患者.
- 进行了单变量和多变量分析.
主要成果:
- 活性化疗显著增加了患COVID-19的可能性 (OR 5.8,P=0.043).
- 没有观察到激素受体状态或乳腺癌阶段的显著差异.
- 在40%的病例中,COVID-19导致治疗延迟,死亡率为4%.
结论:
- 活性化疗是乳腺癌患者COVID-19的重要危险因素.
- 对于三阴性疾病,观察到增加风险的趋势.
- 建议在接受活性化疗的患者继续采取严格的预防措施.
相关概念视频
Cancer Survival Analysis
355
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
355
Comparing the Survival Analysis of Two or More Groups
195
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
195
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
Single Nucleotide Polymorphisms-SNPs
15.1K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.1K
Statistical Methods for Analyzing Epidemiological Data
369
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
369


